ADDED ON ER
Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment